Neogenomics, Inc.

Organisation

9490 NeoGenomics Way, Fort Myers, FL, United States, 33912

Headquarters

2500

Employees

Health Services

Industry

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Price

Target

Neogenomics, Inc. (NEO) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Neogenomics, Inc. (NEO) share price will touch around $14.81 in next 12-months.

Currently 17 wall-street analysts regularly analyze the financials of Neogenomics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Neogenomics, Inc. (NEO) have a share price target of $14.81. This median of share price forecast represents a 91.13% upside from the latest price of $7.75 as on 03.04.26.

Neogenomics, Inc. (NEO) Share Price Forecast

Home

US Stocks

Neogenomics, Inc. (NEO)

Neogenomics, Inc. Stock Forecast

Neogenomics, Inc. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Neogenomics, Inc. (NEO): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Neogenomics, Inc.'s share price and its median forecast price. As on 03.04.26, the difference is -47.68%

Neogenomics, Inc. Forecast and Target Price

Neogenomics, Inc. (NEO) Share Price Forecast

Neogenomics, Inc. (NEO) Price vs Consensus Price Target

Neogenomics, Inc. (NEO) Share Price Forecast v/s Share Price Today

Neogenomics, Inc. (NEO): Difference between Current Price & Median Forecasted Price

Neogenomics, Inc. (NEO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price